2002 - Fellow of the American Academy of Arts and Sciences
1987 - Fellow of the American Association for the Advancement of Science (AAAS)
His scientific interests lie mostly in Microbiology, Enterotoxin, Immunogenicity, Virology and Immunology. His study explores the link between Microbiology and topics such as Toxoid that cross with problems in Immunoglobulin G, Vibrio cholerae and In vitro. His Immunogenicity research is multidisciplinary, relying on both Enterotoxigenic Escherichia coli and Immunity.
His work deals with themes such as Immunization and Recombinant DNA, which intersect with Virology. His Immunology research includes elements of Cytotoxic T cell and Intestinal mucosa. The various areas that John D. Clements examines in his Antigen study include Adjuvant and Antibody.
Microbiology, Immunology, Adjuvant, Immune system and Virology are his primary areas of study. His Microbiology study incorporates themes from Enterotoxigenic Escherichia coli, Heat-labile enterotoxin, Enterotoxin and Immunogenicity. His works in Immunization, Vaccination, Antibody, Immunity and CTL* are all subjects of inquiry into Immunology.
His Adjuvant study combines topics in areas such as T cell, Mutant, Antigen, Bacterial adhesin and Nasal administration. The concepts of his Immune system study are interwoven with issues in Immunogen and Campylobacter. His work carried out in the field of Virology brings together such families of science as Cytotoxic T cell, Feces, Salmonella and Recombinant DNA.
The scientist’s investigation covers issues in Immunology, Microbiology, Adjuvant, Immune system and Antigen. The Immunization, Vaccination, Antibody and Immunity research John D. Clements does as part of his general Immunology study is frequently linked to other disciplines of science, such as Otitis, therefore creating a link between diverse domains of science. His Microbiology research incorporates elements of Enterotoxigenic Escherichia coli, Enterotoxin, Secretion, Toxoid and Vibrio cholerae.
His work deals with themes such as Mucosal vaccine and Vaccine efficacy, which intersect with Adjuvant. Within one scientific family, John D. Clements focuses on topics pertaining to Immunogen under Immune system, and may sometimes address concerns connected to Hepatitis B. His studies deal with areas such as Amino acid, Transfection and Virology as well as Antigen.
John D. Clements mainly investigates Adjuvant, Immunology, Antigen, Immune system and Microbiology. He studied Adjuvant and Immunity that intersect with Diarrhea, Toxin and Recombinant DNA. Immunization, Antibody, Immunogen and Mucosal vaccine are the subjects of his Immunology studies.
The study incorporates disciplines such as Enterotoxigenic Escherichia coli, Escherichia coli, Enterotoxin and Virology in addition to Antigen. His study ties his expertise on Immunogenicity together with the subject of Virology. His research in Immune system is mostly concerned with Bacterial vaccine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.
Carol O. Tacket;Hugh S. Mason;Genevieve Losonsky;John D. Clements.
Nature Medicine (1998)
Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.
Hugh S. Mason;Tariq A. Haq;John D. Clements;Charles J. Arntzen.
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Stephen L. Leib;David Leppert;John Clements;Martin G. Täuber.
Infection and Immunity (2000)
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.
Igor M. Belyakov;Zdenek Hel;Brian Kelsall;Vladimir A. Kuznetsov.
Nature Medicine (2001)
Oral Immunogenicity of Human Papillomavirus-Like Particles Expressed in Potato
Heribert Warzecha;Hugh S. Mason;Christopher Lane;Anders Tryggvesson.
Journal of Virology (2003)
Mechanisms for Mucosal Immunogenicity and Adjuvancy of Escherichia coli Labile Enterotoxin
Ichiro Takahashi;Mariarosaria Marinaro;Hiroshi Kiyono;Raymond J. Jackson.
The Journal of Infectious Diseases (1996)
Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant
Elizabeth B. Norton;Louise B. Lawson;Lucy C. Freytag;John D. Clements.
Clinical and Vaccine Immunology (2011)
Evidence for peripheral clearance of cerebral Aβ protein following chronic, active Aβ immunization in PSAPP mice
Cynthia A Lemere;Edward T Spooner;John LaFrancois;Brian Malester.
Neurobiology of Disease (2003)
Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins.
J D Clements.
Infection and Immunity (1990)
Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa
Igor M. Belyakov;Vladimir A. Kuznetsov;Brian Kelsall;Dennis Klinman.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: